Nebulized mesenchymal stem cell derived conditioned medium ameliorates Escherichia coli induced pneumonia in a rat model

BACKGROUND: Mesenchymal stem cells (MSC) have shown immense therapeutic promise in a range of inflammatory diseases, including acute respiratory distress syndrome (ARDS), and are rapidly advancing through clinical trials. Among their multimodal mechanisms of action, MSCs exert strong immunomodulator...

Descripción completa

Detalles Bibliográficos
Autores principales: González, Héctor E., McCarthy, Sean D., Masterson, Claire, Laffey, John G., MacLoughlin, Ronan, O’Toole, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272576/
https://www.ncbi.nlm.nih.gov/pubmed/37332742
http://dx.doi.org/10.3389/fmed.2023.1162615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272576/
https://www.ncbi.nlm.nih.gov/pubmed/37332742
http://dx.doi.org/10.3389/fmed.2023.1162615

Ejemplares similares